Scandinavian ChemoTech Balance Sheet Health
Financial Health criteria checks 4/6
Scandinavian ChemoTech has a total shareholder equity of SEK9.0M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK14.8M and SEK5.8M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 1.58m |
| Equity | SEK 8.97m |
| Total liabilities | SEK 5.79m |
| Total assets | SEK 14.75m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CMOTEC B's short term assets (SEK8.5M) exceed its short term liabilities (SEK5.8M).
Long Term Liabilities: CMOTEC B has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CMOTEC B is debt free.
Reducing Debt: CMOTEC B has no debt compared to 5 years ago when its debt to equity ratio was 37.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CMOTEC B has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CMOTEC B has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.6% each year